Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis
Abstract Cancer‐associated cachexia (CAC) is a wasting syndrome characterized by involuntary weight loss and anorexia. Clear definition and diagnostic criteria for CAC are lacking, which makes it difficult to estimate its prevalence, to interpret research and to compare studies. There is no standard...
Main Authors: | Lucile Simon, Christine Baldwin, Anastasia Z. Kalea, Adrian Slee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.12861 |
Similar Items
-
Dose‐dependent effect of megestrol acetate supplementation in cancer patients with anorexia–cachexia syndrome: A meta‐analysis
by: Sepide Talebi, et al.
Published: (2024-08-01) -
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
by: Ola Magne Vagnildhaug, et al.
Published: (2024-04-01) -
Natural ghrelin in advanced cancer patients with cachexia, a case series
by: David Blum, et al.
Published: (2021-04-01) -
Real‐world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post‐marketing surveillance in Japan
by: Koichi Takayama, et al.
Published: (2024-05-01) -
Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
by: Daniel I. Brierley, et al.
Published: (2019-08-01)